4
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Incubation Of Autolocous Bone Marrow Graft with Asta Z 7557: Comparative Studies of Hematological Reconstitution After Purged or Nonpurged Bone Marrow Transplantation

, , , , , & show all
Pages 105-115 | Received 12 Jan 1987, Accepted 11 Mar 1987, Published online: 09 Jul 2009

References

  • Hagenbeek A., Martens A. CM. : Detection of minimal residual leukemia utilizing monoclonal antibodies and fluorescence activated cell sorting (FACS). Minimal Disease in Acute Leukemia, B. Löwenbergand, A. Hagenbeek. Martinus Nijhoff, Boston 1984; 45–54
  • Dicke K. A., Spitzer G., Peters L. Autologous bone marrow transplantation in relapsed adult acute leukemia. Lancet 1979; i: 514–517
  • Bast R. C., Jr., De Fabritiis P., Lipton J. Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement. Cancer Res 1985; 45: 499–503
  • Sharkis S. J., Santos G. W., Colvin M. Elimination of acute myelogenous leukemic cells from marrow and tumor suspension in the rat with 4-hydroperoxycyclophosphamide. Blood 1980; 55: 521–523
  • Thomas D., Storb R. Technique for human marrow grafting. Blood 1970; 36: 507–515
  • Beaujean F., Hartmann O., Le Forestier C., Bayet S., Duédari N., Parmentier C. Successful infusion of 40 cryopreserved autologous bone marrows. In vitro studies of the freezing procedure. Biomed Pharmacother 1984; 38: 348–352
  • Gilmore M. JML, Prentice H. G., Blacklock H. A., Ma D. DF, Janossy G., Hoffbrand A. V. A technique for rapid isolation of bone marrow mononuclear cells using Ficoll Metrizoate and the IBM 2991 Blood Cell Processor. Br J Haematol 1982; 50: 619–626
  • Hartmann O., Parmentier C., Lemerle J., Gout M., Schweisguth O. Sequential study of the bone marrow granulocytic progenitor cells (CFC) in children treated by chemotherapy for non Hodgkin lymphomas. Nouv Rev Fr Hematol 1979; 21: 239–245
  • Santos G. W., Kaizer H. : In vitro chemotherapy as a preclude to autologous marrow transplantation in hematologic malignancy. Minimal Residual Disease in Acute Leukemia, B. Lówenberg, A. Hagenbeek. Martinus Nijhoff, Boston 1984; 165–181
  • Korbling M., Dorken B., Haag D., Hunstein W. In vitro treatment of the autologous marrow graft: Quantification of tumor cell elimination by clonogenic assay. Exp Haematol 1984; 12: 423, Abstract 169
  • Uckun F. M., Ramarrishnan S., Haag D., Houston L. L. Ex vivo elimination of lymphoblastic leukemia cells from human marrow by mafosfamide. Leukemia Res 1985; 9: 83–95
  • Rowley S. D., Stuart R. K. 4 Hydroperoxyclophosphamide (4 HC) effects of human pluripotent stem cells (CFU-GEMM) in vitro. Exp Haematol 1984; 11, Abstract 11 (supp 14)
  • Gorin N. C., Douay L., Najman A., Baillou C., Duhamel G. Study of in vitro sensitivity of human leukemic cells and normal hematopoietic progenitors to 4 hydroperoxycyclophosphamide (4 HC). The interest for the preparation of antileukemic autologous bone marrow transplantation. Exp Haematol 1982; 10, Abstract 21 (suppl 11)
  • Herve P., Tamayo E., Peters A. Autologous stem cell grafting in acute myeloid leukaemia: Technical approach of marrow incubation in vitro with pharmacological agents. (Prerequisite for clinical applications). Br J Haematol 1983; 53: 683–685
  • Kaizer H., Stuart R. K., Brookmeyer R. Autologous bone marrow transplantation in acute leukemia: A phase I study of in vitro treatment of marrow with 4-hydroperoxycyclophosphamide to purge tumor cells. Blood 1985; 65: 1504–1510
  • Hartmann O., Beaujean F., Bayet S. Hematopoietic recovery following autologous bone marrow transplantation: Role of cryopreservation, number of cells infused and nature of high-dose chemotherapy. Eur J Cancer Clin Oncol 1985; 21: 53–60
  • Hagenbeek A., Martens A. CM. Toxicity of ASTA Z 7557 (INN mafosfamide) to normal and leukemic stem cells: Implications for autologous bone marrow transplantation. Invest New Drugs 1984; 2: 237–243
  • McElwain T. J., Hedley D. W., Gordon M. Y., Jarman M., Millar J. L., Pritchard J. High-dose melphalan and non-cryopreserved autologous bone marrow. Treatment of malignant melanoma and neuroblastoma. Exp Haematol 1979; 7: 360–371, (supp 5)
  • Yeager A. M., Kaizer H., Santos G. W. Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide. N Engl J Med 1986; 315: 141–147
  • Kovach J. S., Svingen P. A. Antiproliferative activity of 2–[N, N-bis-(2-chloroethyl)-amino]-4–[2-sulfonato-ethylthio]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide cyclohexamine (ASTA Z 7557, INN mafosfamide) against human and murine tumor cells in vitro. Invest New Drugs 1984; 2: 155–159
  • Bénard J., Bettan L., Pico J. L., Hayat M., Kahn E., Riou G. : Detection and chemical elimination of tumoral cells invading the bone marrow. Experimental approaches. Bone Marrow Transplantation in Children, Actualites Carcinologiques. Masson Edts. 1986

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.